These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37936605)

  • 1. Biopsy-proven acute tubulointerstitial nephritis in patients treated with immune checkpoint inhibitors: a pooled analysis of case reports.
    Esposito P; Bottini A; Lecini E; Cappadona F; Piaggio M; Macciò L; Genova C; Viazzi F
    Front Oncol; 2023; 13():1221135. PubMed ID: 37936605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute tubulointerstitial nephritis induced by checkpoint inhibitors versus classical acute tubulointerstitial nephritis: are they the same disease?
    Draibe JB; García-Carro C; Martinez-Valenzuela L; Agraz I; Fulladosa X; Bolufer M; Tango A; Torras J; Soler MJ
    Clin Kidney J; 2021 Mar; 14(3):884-890. PubMed ID: 33777371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint inhibitor-associated nephritis-treatment standard.
    Barbir EB; Kitchlu A; Herrmann SM
    Nephrol Dial Transplant; 2024 Oct; 39(11):1785-1798. PubMed ID: 39138117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations.
    Perazella MA; Sprangers B
    Clin Kidney J; 2021 May; 14(5):1301-1306. PubMed ID: 33970161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis.
    Abdelrahim M; Mamlouk O; Lin H; Lin J; Page V; Abdel-Wahab N; Swan J; Selamet U; Yee C; Diab A; Suki W; Abudayyeh A
    Oncoimmunology; 2021 May; 10(1):1927313. PubMed ID: 34104543
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience.
    Mamlouk O; Selamet U; Machado S; Abdelrahim M; Glass WF; Tchakarov A; Gaber L; Lahoti A; Workeneh B; Chen S; Lin J; Abdel-Wahab N; Tayar J; Lu H; Suarez-Almazor M; Tannir N; Yee C; Diab A; Abudayyeh A
    J Immunother Cancer; 2019 Jan; 7(1):2. PubMed ID: 30612580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition.
    Hakroush S; Kopp SB; Tampe D; Gersmann AK; Korsten P; Zeisberg M; Tampe B
    Front Immunol; 2020; 11():624547. PubMed ID: 33552089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study.
    Zhou P; Liu B; Shen N; Fan X; Lu S; Kong Z; Gao Y; Lv Z; Wang R
    Ren Fail; 2024 Dec; 46(1):2326186. PubMed ID: 38466161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint inhibitors associated granulomatous small vessel vasculitis accompanied with tubulointerstitial nephritis: a case report.
    Tominaga K; Takeuchi K; Takakuma S; Sakamoto E; Hatanaka S; Kajimoto Y; Toda E; Terasaki Y; Kunugi S; Terasaki M; Shimizu A
    BMC Nephrol; 2023 Mar; 24(1):48. PubMed ID: 36894873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
    Sise ME; Wang Q; Seethapathy H; Moreno D; Harden D; Smith RN; Rosales IA; Colvin RB; Chute S; Cornell LD; Herrmann SM; Fadden R; Sullivan RJ; Yang NJ; Barmettler S; Wells S; Gupta S; Villani AC; Reynolds KL; Farmer J
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report.
    Hultin S; Nahar K; Menzies AM; Long GV; Fernando SL; Atkinson V; Cebon J; Wong MG
    BMC Nephrol; 2020 Sep; 21(1):391. PubMed ID: 32894101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
    Koda R; Watanabe H; Tsuchida M; Iino N; Suzuki K; Hasegawa G; Imai N; Narita I
    BMC Nephrol; 2018 Feb; 19(1):48. PubMed ID: 29486725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, predictors and 6-month overall outcome of acute kidney injury in Chinese patients receiving PD-1 inhibitors.
    Qin Z; Liu K; Xu X; Li T; Ge Y; Wu B; Xing C; Mao H
    Future Oncol; 2022 May; 18(16):1951-1962. PubMed ID: 35232231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Spectrum of Biopsy-Proven Kidney Diseases, Causes, and Renal Outcomes in Acute Kidney Injury Patients.
    Abuduwupuer Z; Lei Q; Liang S; Xu F; Liang D; Yang X; Liu X; Zeng C
    Nephron; 2023; 147(9):541-549. PubMed ID: 37094563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors in patients with chronic kidney disease: Assessing their ability to cause acute kidney injury and informing their proper use.
    Min JW; Lim JU
    Semin Oncol; 2022 Apr; 49(2):141-147. PubMed ID: 35264308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience.
    De Giglio A; Grandinetti V; Aprile M; Borelli G; Campus A; Croci Chiocchini AL; Busutti M; Vischini G; Di Federico A; Sperandi F; Melotti B; Ardizzoni A; La Manna G; Gelsomino F
    Lung Cancer; 2022 Dec; 174():91-96. PubMed ID: 36356493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity in the Age of Immune Checkpoint Inhibitors: Mechanisms, Diagnosis, and Management.
    Moturi K; Sharma H; Hashemi-Sadraei N
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors.
    Liu F; Wang Z; Li X; Zhang Z; Yang Y; Chen J; Chen D; Wu L; Liu X; Han S; Wang F; Wahafu W; Gao Y; Ren S; Xing N; Cai G; Chen X
    Cancer Commun (Lond); 2023 Feb; 43(2):214-224. PubMed ID: 36528491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Kidney Injury Induced by Immune Checkpoint Inhibitors.
    Tian R; Liang J; Li R; Zhou X
    Kidney Dis (Basel); 2022 May; 8(3):190-201. PubMed ID: 35702709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy.
    Baker ML; Yamamoto Y; Perazella MA; Dizman N; Shirali AC; Hafez N; Weinstein J; Simonov M; Testani JM; Kluger HM; Cantley LG; Parikh CR; Wilson FP; Moledina DG
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35354588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.